Evaluation of the Safety of Intraarticular Aquamid Reconstruction Injection for Knee Osteoarthritis in Humans
Launched by HENNING BLIDDAL · Feb 21, 2017
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Previously treated with intra-articular Aquamid Reconstruction in the knee for knee osteoarthritis and referred to our clinic for evaluatino of possible adverse device events.
- Exclusion Criteria:
- • - There are no exclusion criteria
About Henning Bliddal
Henning Bliddal is a prominent clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, the organization collaborates with leading researchers and healthcare professionals to design, conduct, and oversee clinical trials across various therapeutic areas. Committed to transparency and quality, Henning Bliddal strives to ensure the integrity of data while fostering a patient-centered approach that prioritizes safety and efficacy in the development of new treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials